On or around 06/07/2019 (Ongoing date of last review)
Filing Date: June 06, 2019
According to the Complaint, Intermolecular is the trusted partner for advanced materials innovation. Advanced materials are at the core of innovation for a wide range of industries including semiconductors, consumer electronics, automotive, and aerospace. The Company has a ten-year track record helping leading companies accelerate and de-risk materials innovation.
This action stems from a proposed transaction announced on May 6, 2019, pursuant to which Intermolecular, Inc. will be acquired by affiliates of Merck KGaA: EMD Group Holding II, Inc.
On May 6, 2019, Intermolecular’s Board of Directors caused the Company to enter into an agreement and plan of merger with Merck. Pursuant to the terms of the Merger Agreement, Intermolecular’s stockholders will receive $1.20 in cash for each share of Intermolecular common stock they own.
On May 28, 2019, Defendants filed a proxy statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.
Company & Securities Information
Defendant: Intermolecular, Inc.
Headquarters: United States
Ticker Symbol: IMI
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Adam Franchi, et al. v. Intermolecular, Inc., et al.